A Single-Center, Phase II Study of mFOLFOXIRI Combined with Camrelizumab and Bevacizumab in the Neoadjuvant Treatment of Non MSI-H/dMMR Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2761907
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Experimental group:mFOLFOXIRI + Camrelizumab + Bevacizumab
Primary outcome(s): Complete remission rate
Study Design: Single arm
创建时间：
2021-12-15
